ACELYRIN (SLRN) - Sotuvning operatsion marjasi

acelyrin.com (SLRN) - korporativ logo

Acelyrin, Inc. (SLRN) oftalmologiya uchun antitanachalarni ishlab chiqishga e'tibor qaratgan bo'lib, bu uning patent salohiyatini qo'llab-quvvatlaydi. Hujayralar tahlilining laboratoriya avtomatlashtirilishi orqali ishlanmalar jadallashmoqda. Operatsion marja egri chizig'i daromadlilik dinamikasini namoyish etadi, bunda ko'rsatkich 0.00 atrofida saqlanmoqda. Biznes makro-barqarorlikka ega, chunki tadqiqot sur'atlari YaIM sikllaridan mustaqil, garchi ular kapital likvidligiga sezgir bo'lib qolayotgan bo'lsa-da.

acelyrin.com (SLRN): Operatsion foyda normasi 21.02.2024dan 31.05.2025gacha

ACELYRIN (SLRN) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:ACELYRIN Inc., SLRN
acelyrin.com asosiy tovari

Acelyrin, Inc. yuqori xavfli biofarmatsevtika sektorida faoliyat yuritadi, bu yerda operatsion marja tushumni soliqlar va foizlardan oldingi operatsion foydaga aylantirish samaradorligini o'lchaydi. Klinik sinovlar uchun intensiv kapital sarfi va raqobatni hisobga olgan holda, operatsion marja tendentsiyasi investorlarga biznes modelining moliyaviy tahdidlarga chidamliligini baholash imkonini beradi va bozor eyforiyasi cho'qqisida aktivni sotib olishdan saqlaydi.

Raqobatchilar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|TNF Pharmaceuticals - Operatsion foyda marjasi|Operatsion marja YCBD|Operatsion marja PainReform Ltd. (PRFX)|Operatsion rentabellik Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operatsion foyda marjasi|OptiNose - Operatsion marja|Operatsion foyda marjasi PIRS|PROC: Operatsion marja|Petros - Operatsion foyda normasi|Sotuvning operatsion marjasi QLI|Operatsion marja TFF Pharmaceuticals, Inc.